Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy. JCO Precis Oncol. 2022 Mar;6:e2000368. doi:10.1200/PO.20.00368.
Hiroko Masuda H, Kenichi Harano K, Mira S, Wang Y, Yuko Hirota, Harada O, et al.Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Maior Asian Territories. J Breast Cancer. 2022 Jun;25(3):e21 Ithimaki S, Parinyanitikul N, Kim SB, Yap YS, Tsan J, et al.
Autoimmune hemolytic anemia, rare immune-related adverse event after the combination of atezolizumab and paclitaxel treatment in recurrent triple-negative breast cancer: A case report. J Med Case Rep Case Series 2021.
Sintawichai N. Lawasut P, Poovorawan N. Parinyanitikul N.: Case report What is the best systemic treatment for newly diagnosed inflammatory breast cancer? A narrative review. Chin Clin Onco 2021 Oct 19;Cco-21-81.
Chainitikun S, Mingmalairak S, Parinyanitikul N.: Review Article Lactic acidosis, potential toxicity from drug-drug interaction related to concomitant ribociclib and metformin in preexisting renal insufficiency: A case report. Cancer Rep (Hoboken) 2021 Nov 5;e15 75. doi: 10.1002 / cnr2.1575 Lagampan C, Poovorawan N, Parinyanitikul N.: Case report
Call Us
Hi! How can we help you?